Dr. Allen Lai wins the Executive of the Year – Biotechnology award in Singapore Business Review Management Excellence Awards 2018! Under the leadership of Dr. Lai, ACT Genomics Singapore’s cancer diagnostics platform was listed in more than 100 hospitals in Southeast Asia within two years. The company’s revenue has grown substantially to more than 10 times.
“This award affirms the business direction and business model that ACT Genomics Singapore leads. With new markets opening up later this year and next year, we expect a strong growth in our business across emerging markets. We are honored to be recognized in Singapore for spearheading cutting edge molecular diagnostics and benefit more cancer patients at local and from the region,” Dr. Lai said.